agilon health vs DaVita
AGL and DVA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AGL and DVA compare
DaVita is the larger company, worth 5.7 times as much as agilon health ($11.0B against $1.9B).
DaVita grew revenue faster over the last twelve months (6.4% versus 2.0% for agilon health).
DaVita keeps more of each dollar of sales as profit, with a net margin of 6.5% compared with −1.5% at agilon health.
DaVita scores higher on the StockData Score (14 against 4 for agilon health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AGL | DVA |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $11.0B |
| Share price | $115.66 | $174.56 |
| Change, 1 year | 637% | 41.2% |
| Change, 5 years | −80.5% | 75.3% |
| Beta (5Y) | 1.28 | 0.36 |
| Employees | 856 | 78K |
| StockData Score | ||
| Total score | 4 | 14 (better) |
| Valuation score | 1 | 6 (better) |
| Growth score | 1 | 4 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 12.9× |
| P/S | 0.3× (better) | 0.8× |
| EV/EBITDA | – | 7.6× |
| P/FCF | – | 8.5× |
| PEG | – | 0.68 |
| FCF yield | −0.88% | 11.8% (better) |
| Fair value | – | $310.81 |
| Margin of safety | – | 43.8% |
| Growth | ||
| Revenue growth (TTM) | 2.0% | 6.4% (better) |
| Revenue growth, 5Y average | 37.2% (better) | 3.4% |
| Net income growth (TTM) | – | 19.2% |
| EPS growth (TTM) | – | 39.9% |
| EPS growth, 5Y average | – | 9.3% |
| Profitability | ||
| Operating margin | −2.6% | 15.0% (better) |
| Net margin | −1.5% | 6.5% (better) |
| FCF margin | −0.28% | 9.1% (better) |
| Return on invested capital | – | 18.1% |
| Financial health | ||
| Net debt / EBITDA | – | 3.63 |
| Interest coverage | −22.4× | – |
| Current ratio | 1.13 | 1.41 (better) |
| Altman Z-score | 2.87 (better) | 1.69 |
| Piotroski F-score | 2 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 6.6% |
| Shareholder yield | 0.00% | 6.6% (better) |
| Ownership | ||
| Held by institutions | 95.8% | 93.9% |
| Held by insiders | 10.1% | 59.2% |
| Insider net buying, 12 months | $300K (better) | −$523M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 5.6% | 20.0% |
Go deeper
- AGL stock overview
- AGL income statement
- AGL valuation and score
- DVA stock overview
- DVA income statement
- DVA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.